So it can’t buy off competitors to keep prices high
intellectual property
Posted inHealth and Social Policy
Biden Executive Order Could Finally Lower Drug Prices
Several tools could lower prices directly—and serve as an indirect incentive to get Congress to act.
Posted inPolitics
Biden Will Nominate Industry Ally for Patent Office
It’s an about-face from the president’s previous commitment to waive patent protections for COVID-19 vaccines.
Posted inBooks, Arts and Culture
Stealing Ur Website
Innovations in journalistic pilferage at the Financial Times
Posted inCabinet Watch
Chris Coons Working to Install Business-Friendly Candidate for Key Patent Position
The Delaware senator wants a say in the next director of the U.S. Patent and Trademark Office, and claims to have a deal with the White House.
Posted inTAP
Bipartisanship Lives! The Amazing Convergence on China Policy
Today on TAP: In the case of China, Republicans don’t mind letting Democrats lead
Posted inTAP
The Vaccine Waiver Invites Reform of Intellectual-Property Abuses
Today on TAP: The patent system no longer works to promote and reward invention
Posted inCoronavirus
Will Biden Favor Drug Companies—or Billions of People Needing COVID Vaccines?
As the global humanitarian crisis deepens, so far the U.S. government is siding with Big Pharma.
Posted inMoney, Politics, and Power
Place Human Lives Over Pharma’s Property Rights
The Biden administration is divided over whether to waive trade protections for Big Pharma—with Commerce Secretary Gina Raimondo as a key industry ally.